Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform [TheStreet.com]
NORTHWEST BIOTHRPUTCS INC (NWBO)
US:NASDAQ Investor Relations:
nwbio.com/investors-media
Company Research
Source: TheStreet.com
April 30, 2026 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced the appointment of Annalisa Jenkins, M.B.B.S., F.R.C.P., as a Strategic Adviser. Dr. Jenkins brings over 25 years of biopharma leadership, spanning global R&D executive roles at major pharmaceutical companies, biotech CEO roles, membership on the U.S. FDA Science Board and a distinguished record of identifying and developing innovative new technologies. Dr. Jenkins' role with NWBio will help support the continued development and expansion of the Company's dendritic cell-based cancer vaccine platform technology and programs. Dr. Jenkins is a biopharma thought leader, recently honored with the Order of the British Empire (OBE) for her contributions to life sciences and global health leadership. She has an exceptional track record of building and financing biotech companie
Show less
Read more
Impact Snapshot
Event Time:
NWBO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NWBO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NWBO alerts
High impacting NORTHWEST BIOTHRPUTCS INC news events
Weekly update
A roundup of the hottest topics
NWBO
News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine PlatformPR Newswire
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine PlatformPR Newswire
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic [TheStreet.com]TheStreet.com
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis ClinicPR Newswire
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis ClinicPR Newswire
NWBO
Sec Filings
- 5/15/26 - Form 10-Q
- 4/21/26 - Form EFFECT
- 4/16/26 - Form POS
- NWBO's page on the SEC website